======= PDE7B =======
== Gene Information ==
* **Official Symbol**: PDE7B
* **Official Name**: phosphodiesterase 7B
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27115|27115]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NP56|Q9NP56]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PDE7B&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PDE7B|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/604645|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a cAMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family.[provided by RefSeq, Apr 2009].
* **UniProt Summary**: Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in the control of cAMP-mediated neural activity and cAMP metabolism in the brain.
|PDEase I|
|cAMP catabolic process|
|3,5-cyclic-AMP phosphodiesterase activity|
|cyclic nucleotide catabolic process|
|cAMP metabolic process|
|purine ribonucleotide catabolic process|
|ribonucleotide catabolic process|
|cyclic nucleotide metabolic process|
|purine nucleotide catabolic process|
|purine-containing compound catabolic process|
|nucleotide catabolic process|
|nucleoside phosphate catabolic process|
|nucleobase-containing small molecule biosynthetic process|
|organophosphate catabolic process|
|carbohydrate derivative catabolic process|
|purine ribonucleotide metabolic process|
|ribonucleotide metabolic process|
|purine nucleotide metabolic process|
|ribose phosphate metabolic process|
|purine-containing compound metabolic process|
|nucleobase-containing compound catabolic process|
|chemical synaptic transmission|
|anterograde trans-synaptic signaling|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|trans-synaptic signaling|
|aromatic compound catabolic process|
|nucleotide metabolic process|
|nucleoside phosphate metabolic process|
|synaptic signaling|
|organic cyclic compound catabolic process|
|nucleobase-containing small molecule metabolic process|
|small molecule biosynthetic process|
|organophosphate metabolic process|
|carbohydrate derivative metabolic process|
|organonitrogen compound catabolic process|
|nucleobase-containing compound biosynthetic process|
|cell-cell signaling|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|G protein-coupled receptor signaling pathway|
|cellular nitrogen compound biosynthetic process|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|-2.1|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13846
* **Expression level (log2 read counts)**: 1.36
{{:chemogenomics:nalm6 dist.png?nolink |}}